Remifentanil-induced cerebral blood flow effects in normal humans: Dose and ApoE genotype

Anesthesia and Analgesia

Volumn 105, Issue 1, 2007, Pages 167-175

  Kofke, W Andrew ^a,d   Blissitt, Patricia A ^b   Rao, Hengyi ^a   Wang, Jiongjiong ^a   Addya, Kathakali ^a   Detre, John ^a,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; OPIATE; REMIFENTANIL;

ADULT; AMYGDALOID NUCLEUS; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BRAIN BLOOD FLOW; CINGULATE GYRUS; CLINICAL ARTICLE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; INSULA; LIMBIC SYSTEM; MALE; NEUROTOXICITY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THALAMUS;

ADULT; APOLIPOPROTEIN E4; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; HUMANS; LIMBIC SYSTEM; MALE; PIPERIDINES; REGIONAL BLOOD FLOW;

EID: 34250891312     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000266490.64814.ff     Document Type: Article

References (39)

1. Moller J, Cluitmans P, Radmussen L, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning C, Langeron O, Johnson T, Lauven P, Kristensen P, Biedler A, Beem H, Fraidakis O, Silverstein J, Beneken J, Gravenstein J. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. Internation Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857-61.
2. Monk T, Garvin C, Dede D, Gravenstein J. Postoperative cognitive dysfunction following major surgery is more common in elderly patients. Proceedings of AUA, Deptartment of Anesthesiology, University of Rochester, 2001:21.
3. Ancelin M, De Roquefeuil G, Ledésert B, Bonnel F, Cheminal J, Ritchie K. Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry 2001;178:360-6.
4. Hlatky M, Bacon C, Boothroyd D, Mahanna E, Reves J, Newman M, Johnstone I, Winston C, Brooks M, Rosen A, Mark D, Pitt B, Rogers W, Ryan T, Blumenthal J. Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. Circulation 1997;96:11-14.
5. Newman M, Kirchner J, Phillips-Bute B, Gaver V, Grocott H, Jones R, Mark D, Reves J, Blumenthal J; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronalry-artery bypass surgery. N Engl J Med 2001;344:395-402.
6. Heyer EJ, Sharma R, Rampersad A, Winfree CJ, Mack WJ, Solomon RA, Todd GJ, McCormick PC, McMurtry JG, Quest DO, Stern Y, Lazar RM, Connolly ES. A controlled prospective study of neuropsychological dysfunction following carotid end-arterectomy. Arch Neurol 2002;59:217-22.
7. Kofke W, Attaallah A, Kuwabara H, Garman R, Sinz E, Barbaccia J, Gupta N, Hogg J. Neuropathologic effects in rats and neurometabolic effects in humans of high-dose remifentanil. Anesth Analg 2002;94:1229-36.
8. Tempelhoff R, Modica P, Bernardo K, Edwards I. Fentanyl-induced electrocortographic seizures in patients with complex partial epilepsy. J Neurosurg 1992;77:201-8.
9. Wagner KJ, Willoch F, Kochs EF, Siessmeier T, Tolle TR, Schwaiger M, Bartenstein P. Dose-dependent regional cerebral blood flow changes during remifentanil infusion in humans: a positron emission tomography study. Anesthesiology 2001;94:732-9.
10. Kofke W, Garman R, Tom W, Rose ME, Hawkins RA. Alfentanil-induced hypermetabolism, seizure, and neuropathology in rats. Anesth Analg 1992;75:953-64.
11. Tommasino C, Maekawa T, Shapirio H. Fentanyl-induced seizures activate subcortical brain metabolism. Anesthesiology 1984;60:283-90.
12. Young M, Smith D, Greenburg J, Reivich M, Harp J. Effects of sufentanil on regional cerebral glucose utilization in rats. Anesthesiology 1984;61:564-8.
13. Kofke W, Garman R, Janosky J, Rose M. Opioid neurotoxicity: neuropathologic effects of different fentanyl congeners and effects of hexamethonium-induced normotension. Anesth Analg 1996;83:141-6.
14. Kofke W, Garman R, Stiller R, Rose M, Garman R. Opioid neurotoxicity: fentanyl dose response effects in rats. Anesth Analg 1996;83:1298-306.
15. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA. Apoliprotein E allele *4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-90.
16. Roses A, Saunders A. ApoE, Alzheimer's disease, and recovery from brain stress. Ann N Y Acad Sci 1997;826:200-12.
17. Reiman E, Chen K, Alexander G, Caselli R, Bandy D, Osborne D, Saunders A, Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004;101:284-9.
18. Reiman E, Chen K, Alexander G, Caselli R, Bandy D, Osborne D, Saunders A, Hardy J. Correlations between apolipoprotein E epsilon 4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 2005;102:8299-302.
19. Kim S. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 1995;34:293-301.
20. Wang J, Alsop D, Li L, Listerud J, Gonzalez-At JB, Schnall MD, Detre JA. Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4 telsa. Magn Reson Med 2002;48:242-54.
21. Matson G. An integrated program for amplitude-modulated RF pulse generation and re-mapping with shaped gradients. Magn Reson Imaging 1994;12:1205-25.
22. Alsop D, Detre J. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236-49.
23. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-89.
24. McCarron M, Muir K, Nicoll J, Stewart J, Currie Y, Brown K, Bone I. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol 2000;57:1480-4.
25. Kearse LJ, Koski G, Husain MV, Philbin DM, McPeck K. Epileptiform activity during opioid anesthesia. Electroencephalogr Clin Neurophysiol 1993;87:374-9.
26. Floyd T, Clark J, Gelfand R, Detre J, Ratcliffe S, Guvakov D, Lambertsen C, Eckenhoff R. Independent cerebral vasoconstrictive effects of hyperoxia and accompanying arterial hypocapnia at 1 ATA [clinical trial]. J Appl Physiol 2003;95:2453-61.
27. Ramsay S, Murphy K, Shea S, Friston K, Lammertsma A, Clark J, Adams L, Guz A, Frackowiak R. Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task. J Physiol 1993;471:521-34.
28. Proakis A, Harris G. Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs. Anesthesiology 1978;48:339-44.
29. Jacot A, Bissonnette B, Favre J, Ravussin P. The effect of ondansetron on intracranial pressure and cerebral perfusion pressure in neurosurgical patients. Ann Fr Anesth Reanim 1998;17:220-6.
30. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997;86:24-33.
31. GlaxoSmithKline. Ultiva (remifentanil hydrochloride) Product Information Available at: www.gsk.com.au/resources.ashx/ prescriptionmedicinesproductschilddataproinfo/230/FileName/ 89C5B965A0FC77C792A0E9427B5CF7F9/PI_Ultiva.pdf. Accessed December 1, 2006, 2003.
32. Firestone L, Gyulai F, Mintun M, Adler L, Urso K, Winter P. Human brain activity response to fentanyl imaged by positron emission tomography. Anesth Analg 1996;82:1247-51.
33. Farr S, Uezu K, Creonte T, Flood J, Morley J. Modulation of memory processing in the cingulate cortex of mice. Pharmacol Biochem Behav 2000;65:363-8.
34. Ennaceur A, Neave N, Aggleton J. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 1997;113:509-19.
35. Gutierrez H, Hernandez-Echeagaray E, Ramirez-Amaya V, Bermudez-Rattoni F. Blockade of N-methyl-D-aspartate receptors in the insular cortex disrupts taste aversion and spatial memory formation. Neuroscience 1999;89:751-8.
36. Steed L, Kong R, Stygall J, Acharya J, Bolla M, Harrison M, Humphries S, Newman S. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg 2001;71:823-6.
37. Abildstrom H, Christiansen M, Siersma VD, Rasmussen LS. Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology 2004;101:855-61.
38. Heyer E, Wilson D, Sahlein D, Mocco J, Williams S, Sciacca R, Rampersad A, Komotar R, Zurica J, Benvenisty A, Quest D, Todd G, Solomon R, Connolly EJ. APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy. Neurology 2005;65:1759-63.
39. Kofke W, Konitzer P, Meng Q, Guo J, Cheung A. Effect of Apolipoprotein E genotype on NSE and S-100 levels after cardiac and vascular surgery. Anesth Analg 2004;99:1323-5.